Bluejay Diagnostics BJDX
NASDAQ BJDX
$2.47 +0.15 (+6.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Bluejay Diagnostics (BJDX) Gains (Losses) on Sale of Assets & Investments (2022)

Updated

Bluejay Diagnostics' Non Operating Investment Income came in at -$210,117 for Q3 2022.

Analysis

Bluejay Diagnostics (BJDX) Gains (Losses) on Sale of Assets & Investments (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn -
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn -
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn -
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn -
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn -
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn -
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn -
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn -
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn -
10 Bluejay Diagnostics 5.18 Mn -16.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -210,117.00
API Access

Bluejay Diagnostics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BJDX&period=max&api_key=YOUR_API_KEY